Leading International Medical Cannabis Business

Expressions of Interest By:

Under Offer

DOWNLOAD NDA

Project Indica

Hilco are pleased to offer for sale the business and assets of a leading international medical cannabis group providing clinical care and pharmacy dispensing in the UK and Australia, along with own leading product brand.

The Opportunity

• Operating in one of Europe’s fastest growing industries and forming part of a multi-million global marketplace
• A vertically integrated scalable business facilitating patient access to medical cannabis in the UK and Australia
• The Group has three main business units spanning product supply, clinical care and pharmacy dispensing
• Established market presence with proven track record and opportunities to expand into other markets

The Business

• Founded in 2019 as a pioneer within the newly created UK medical cannabis market following its legalisation in November 2018, the business has established itself as one of the largest operators in the UK
• Trading across a number of wholly owned subsidiary companies the group operates a direct to consumer business model for the supply, prescription and pharmacy dispensing of medical cannabis products
• Income generated from three main streams comprising product sales, clinics and online pharmacy dispensing
• Recent entrant into the Australian market with clinics and wholesale revenues
• Experienced management team and established workforce
• Significant brand equity established over the Company’s trading period
• Current run rate of c.£10m per annum
• Revenues for Y/E 30th September 2023 c.£8.2m and c.£7.7m for Y/E 2022

Group Assets

The Group’s assets include:

The Subsidiary Operating Companies – The group comprises a number of wholly owned subsidiary operating companies, which include the product brand range, clinical care and pharmacy dispensary businesses.

Intellectual Property Assets – The established brand name and trademarks, copyright in the website content and domain names; and existing policies and protocols produced in relation to compliance and governance as a regulated business. In addition, the Company has developed a custom built in-house pharmacy tech platform and a training programme for Doctors.

The Licences – The company holds all the required regulatory licences and permits for business operations within the relevant subsidiary companies.

Goodwill – The goodwill established since the formation of the business.